Medical Device and Combination Product Specialty Section
The medical device industry is a rapidly growing, $500 billion dollar enterprise that produces a diverse range of products. The role of toxicologists in the evaluation of medical devices is evolving in response to a number of factors, including changing regulatory paradigms, use of novel materials, development of combination products, and increased public concern about potential exposure to medical device chemical components. The Medical Device and Combination Product Specialty Section (MDCPSS) was formed in Fall of 2009, with the purpose of providing an international forum where government, industry, and academic toxicologists can share state-of-the-art knowledge and develop new approaches for the evaluation of medical devices.
Our members are a dynamic mix of scientists from device manufacturing companies, CROs, regulatory agencies, and consulting companies; we are actively seeking members among academic faculty and students. Our specific areas of interest include: plastics, metals, ceramics, materials of biologic origin, and validation of new/alternative toxicology assays for medical devices.
The objectives of the MDCPSS are: